In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer. Top experts in the field cover key topics such as pancreatic adenocarcinoma:: trends in epidemiology, risk factors, and outcomes; decision making regarding perioperative therapy in individuals with localized pancreatic adenocarcinoma; the evolving role of radiotherapy in the management of individuals with pancreatic adenocarcinoma; and more.
Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes What Can We Learn About Pancreatic Adenocarcinoma from Imaging? Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma Radiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon Cytotoxic Chemotherapy in Advanced Pancreatic Cancer PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma Genetics of Pancreatic Neuroendocrine Tumors Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.